Implantation - Alpha Bio®
Implantation
Nobel Alpha Implant
Alpha-Bio Tec specializes in developing and producing advanced dental solutions, focusing on the field of implants and prosthetics.
Since entering the market 20 years ago, Alpha-Bio Tec has developed a long list of innovative products designed to provide dentists with the most comprehensive and efficient array of services.
In order to assure that its products are optimally suited to meet the doctor's changing needs, Alpha-Bio Tec has established a research and development team comprised of experts in the field of dentistry. The team members are dedicated to conducting thorough studies all year long, the results of which lie at the root of the methods and products developed by Alpha-Bio Tec.
Alpha-Bio Tec sustains a meticulous quality control system and complies with major quality control standards: ISO 13485:2003 under the Canadian Medical Devices Conformity Assessment System, ISO 9001:2000 and Council Directive 93/42/EEC. Alpha-Bio Tec's products are CE-approved and cleared for marketing in the USA.
The implants, prosthetics and accompanying aids manufactured by Alpha-Bio Tec naturally integrate into the body, cut the recovery time short, prevent complications and provide durability for years.
In addition, the surface of Alpha-Bio Tec's implants undergoes a complex process, which significantly increases the implant's ability to bond with the bone (osseointegration).
Quality Assurance
The Alpha-Bio Tec Quality System commitment is to ensure that Alpha-Bio Tec's medical devices are with compliance to international standards and requirements. To ensure constant adequacy and effectiveness to these standards and to comply with all regulatory requirements Alpha-Bio Tec maintains a high standard of Quality Assurance system.
Alpha-Bio Tec's Medical devices are:
- CE-approved
- Clear for marketing in the USA.
Alpha-Bio Tec complies with major quality control standards:
- ISO 13485:2003 including the Canadian Medical Devices Conformity Assessment System
- ISO 9001:2000
- Council Directive 93/42/EEC
About the System - In Harmony with Nature
Designing a successful implant system requires a great deal of knowledge about biology and mechanics, but also the awareness of how the two interact. In the development of Alpha-Bio Tec's implant series we acknowledge the value of Harmony.
Our slogan "In Harmony with Nature" emphasizes the essence of Alpha-Bio Tec's implant system. Our main goal is to gain the ultimate integration between the human body and Alpha-Bio Tec's implants. With the NanoTec implant surface, we have taken it to the next level by helping our implants integrate naturally with the human body. In Alpha-Bio Tec we believe that initial bone healing and long-term marginal bone stability are affected by the implant's design and surface properties. Successful clinical results, in both short and long-term perspective, are related to the features of an implant.
Alpha-Bio Tec's implant system is designed to provide the ultimate substitute for natural teeth, with the right conditions. All of the system's parts work together for reliable clinical success. The system offers a wide range of products, including implants and prosthetic parts, designed in one platform that fits all implant diameters.
The unique and simple system makes the dentist's work extremely convenient and accomplishes several major advantages:
- Wide range of products with proven clinical biocompatibility
- Fast and easy insertion
- High primary stability
- High predictability
- High success rates, in immediate loading
NanoTec Implant Surface
The implant surface is key in achieving optimal Osseointegration. It is well documented that the surface characteristics of implanted materials can influence the healing and growth of tissues adjacent to the implant surface.
After more than 5 years of intensive research Alpha-Bio Tec has developed a superior NanoTec surface for its implants. Alpha-Bio Tec's NanoTec implant surface is a sandblast large particles acid etched surface. The NanoTec implant surface enables the absorption of blood directly into its micropores immediately after the implant placement.The NanoTecTM implant surface promotes healing and growth of tissues adjacent to the implant surface, thus accelerating and improving the osseointegration process.
Alpha Bio Tec's NanoTec implant surface is treated with sand blasting to create a macro surface of 20-40 micron. Afterwards it undergoes a double thermal acid etching process to create micro pitting between 1 to 5 micron with nano-pitting. The implant surface then undergoes a treatment to build a titanium oxide layer.
Retrospective clinical data shows that Alpha-Bio Tec's implants achieve an overall clinical success rate of 98.3% and a 99.6% clinical success rate when using the immediate loading procedure.
NanoTec advantages:
- Increased early bone to implant contact
- Increased stability
- Shortened healing period
- Higher predictability
Media Release
Zurich - 7 February 2008
Nobel Biocare signs agreement to acquire AlphaBioTec
Nobel Biocare announced today that it has agreed to acquire AlphaBioTec Ltd, the leading dental implant company in Israel and the innovator of the predecessor to NobelActive. Nobel Biocare will buy all outstanding shares in the company for a consideration of USD 95 million.
With this acquisition, Nobel Biocare will reinforce its leading position by gaining immediate access to some of the fastest-growing market segments in implant dentistry, such as orthodontic mini-screws and small diameter implants. At the same time, the company will gain a market leadership position in Israel and further expand its position in Russia, Poland and Latin America.
With a market share of more than 60 percent, AlphaBioTec is the leading dental implant company in Israel. AlphaBioTec products are also sold in more than 40 countries, and its export business has been growing at a pace in excess of 35 percent over the past several years. AlphaBioTec has achieved leading positions in high-growth countries in Eastern Europe, Russia and is expanding quickly in India, Korea and Latin America. AlphaBioTec has more than 20 years of experience in implant dentistry and is the innovator of NobelActive's predecessor product. Nobel Biocare's NobelActive is currently in pre-launch and is expected to be introduced to the market in the second quarter of this year.
Nobel Biocare will obtain all rights to AlphaBioTec's trademark, brand names, innovation pipeline, strong R&D network and proprietary manufacturing facility in Tel Aviv. Nobel Biocare will retain all of AlphaBioTec's more than 120 employees. Ophir Fromovich, the current owner and CEO, will become Chairman of the Board of AlphaBioTec and act as an advisor to Nobel Biocare.
Domenico Scala, CEO of Nobel Biocare: "This acquisition expands Nobel Biocare's leading position by allowing us to enter new and fast-growing market segments. AlphaBioTec's leading position in Israel, its attractive pipeline and strong innovation skills with excellent people will complement our innovation capabilities."
Under the terms of the agreement, the acquisition will be paid in cash and existing Nobel Biocare shares. The transaction is expected to close in the second quarter of 2008 and be accretive from the first year.
